AJAI KALLA: Open Payments
NPI 1245327998 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 16 payments from 7 companies in 2025. Trend: 2023 $711 · 2024 $666 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $111 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: ARISTADA, COBENFY, UZEDY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, Auvelity.
Industry payments across GA — which companies pay providers there.
